User profiles for Ruveyda Ayasun
 | Ruveyda Ayasun, MD, PhDNYU Langone Health Verified email at nyulangone.org Cited by 305 |
The role of HER2 status in the biliary tract cancers
Simple Summary Human epidermal growth factor receptor-2 (HER2) plays a critical role in
breast and gastric cancer. More recently, a growing body of literature demonstrated that …
breast and gastric cancer. More recently, a growing body of literature demonstrated that …
[PDF][PDF] Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence
Immunotherapy has revolutionized cancer treatment, yet most patients do not respond. Here,
we investigated mechanisms of response by profiling the proteome of clinical samples from …
we investigated mechanisms of response by profiling the proteome of clinical samples from …
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
Sarcoidosis is an idiopathic inflammatory disorder that is commonly treated with glucocorticoids.
An imprecise understanding of the immunologic changes underlying sarcoidosis has …
An imprecise understanding of the immunologic changes underlying sarcoidosis has …
Systemic therapy for patients with pancreatic cancer: current approaches and opportunities for novel avenues toward precision medicine
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis with a 5-year overall
survival of 11%. The disease is usually diagnosed at advanced stages, and systemic …
survival of 11%. The disease is usually diagnosed at advanced stages, and systemic …
Cutaneous findings in Inborn Errors of Immunity: An immunologists perspective
Cutaneous manifestations are common in patients with inborn errors of immunity (IEI)/primary
immunodeficiency (PID) and could be due to infections, immune dysregulation, or …
immunodeficiency (PID) and could be due to infections, immune dysregulation, or …
Targeting KRAS oncogene for patients with colorectal cancer: A new step toward precision medicine
KRAS mutations are common driver oncogenes associated with the development of several
solid tumors. KRAS oncogene has been considered a highly challenging target for drug …
solid tumors. KRAS oncogene has been considered a highly challenging target for drug …
A multivalent peptoid conjugate modulates androgen receptor transcriptional activity to inhibit therapy-resistant prostate cancer
Prostate cancers adapt to androgen receptor (AR) pathway inhibitors and progress to castration
resistance due to ongoing AR expression and function. To counter this, we developed a …
resistance due to ongoing AR expression and function. To counter this, we developed a …
Trastuzumab plus FOLFOX for HER2-positive biliary tract cancer
… We express our sincere gratitude to Ruveyda Ayasun and Ilyas Sahin for their letter regarding
our study, 1 which investigated the effect of trastuzumab plus FOLFOX as a second-line or …
our study, 1 which investigated the effect of trastuzumab plus FOLFOX as a second-line or …
Effects of Clinical and Tumor Characteristics on Survival in Patients with Hepatocellular Carcinoma with Bone Metastasis
Background Advanced hepatocellular carcinoma (HCC) generally has a dismal prognosis.
Bone metastases from HCC are infrequent, with a poorer prognosis. However, the survival …
Bone metastases from HCC are infrequent, with a poorer prognosis. However, the survival …
Treatment of sarcoidosis with cutaneous involvement with tofacitinib
Sarcoidosis is an idiopathic inflammatory disorder that is commonly treated with glucocorticoids
and there are no approved steroid-sparing medications. There is emerging evidence …
and there are no approved steroid-sparing medications. There is emerging evidence …
